Skip to main content
. 2015 Apr 10;5(1):135–146. doi: 10.1159/000375527

Table 2.

Demographic features of the patients

Donepezil (n = 19) Rivastigmine (n = 17) Galantamine (n = 19)
Age, years 78.4±6.5 77.2±5.4 77.4±6.0
Gender, men/women 9/10 8/11 8/9
Length of education, years 12.3±2.4 13.2±3.0 11.0±2.5
Duration of disease, years 3.1±0.8 2.6±0.9 3.2±0.8
APOE ε4 carrier, n (%) 10 (52.6) 9 (52.9) 9 (47.4)
Duration of medication, months 12.3±2.4 12.8±1.8 11.8±2.2

APOE = Apolipoprotein E.